MAPT and Alzheimer disease: In general, researchers start with a vanilla VAE and apply slight modifications to fit their data modality and goal to detect and predict diseases, including multiple sclerosis [127], Alzheimer disease (AD) [128-131], tau biomarker detection for AD [132], glaucoma [133], and lung cancer [134].